GlassScriptPhysician profile
Juhi Shukla
NPI 1427500339
$2,702.30
in general payments reported to CMS, 2019-2025
27 companies · $373 in 2025
The $373 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $287 · 2020: $18.58 · 2021: $608 · 2022: $585 · 2023: $293 · 2024: $537 · 2025: $373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,203.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $753.44 | 2019-2024 | Lo Loestrin Fe, Liletta |
| Sumitomo Pharma America, INC. | $245.92 | 2023-2025 | Myfembree, Gemtesa |
| Myovant Sciences INC. | $206.23 | 2021-2022 | |
| Daiichi Sankyo INC. | $193.03 | 2019-2025 | Injectafer |
| Exeltis, USA INC. | $172.79 | 2023-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $139.23 | 2019-2025 | |
| Astellas Pharma US INC | $134.54 | 2023-2024 | Veozah |
| Pfizer INC. | $103.08 | 2022-2023 | |
| Coopersurgical, INC. | $96.98 | 2021-2025 | Paragard T 380a |
| Evofem Biosciences, INC. | $83.47 | 2021-2025 | Solosec, Phexx, Phexxi |
| Terumo Medical Corporation | $76.56 | 2021 | |
| Sage Therapeutics, LLC | $59.82 | 2025 | Zurzuvae |
| Mylan Pharmaceuticals INC. | $54.30 | 2022 | |
| Ethicon US, LLC | $47.64 | 2024 | Enseal |
| Millicent US INC | $46.64 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $46.23 | 2024 | Ova1 |
| Conmed Corporation | $37.64 | 2024-2025 | Airseal |
| Davol INC. | $30.61 | 2021 | |
| Organon LLC | $25.22 | 2025 | Nexplanon |
| Meditrina | $23.25 | 2025 | |
| Boston Scientific Corporation | $20.86 | 2023 | Spaceoar Vue System - 10ml |
| Renovia INC | $20.13 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $19.86 | 2024 | |
| Therapeuticsmd, INC. | $19.10 | 2022 | |
| Hologic Sales and Service, LLC | $17.05 | 2025 | Myosure Tissue Removal Device |
| Olympus America INC. | $16.85 | 2023 | Olympus |
| Mayne Pharma Commercial LLC | $11.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juhi Shukla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.